Increased interest from institutional investors is driving the increasethanks in part to the lower fees charged by CITs.

Senator Patty Murray, D-Washington, has questioned new Centers for Disease Control and Prevention director Brenda Fitzgeralds over financial holdings that could prevent her from talking about cancer and prescription drug monitoring programs.

What do HR executives and the brokers who support them need to know about opioids to help improve health outcomes and lower costs due to unnecessary use of these often harmful medications?

Twenty million Americans are employed by firms with 20 or fewer employees, many of which do not provide health care coverage for their employees.

A spate of hospital deals stands to further remake the U.S. health-care landscape, pushing up prices for consumers and insurers and changing how individuals get care.

The nations most influential science advisory group will tell Congress today that the U.S. pharmaceutical market is not sustainable and needs to change.

For small, rural hospitals across the country, labor, drug, and technology costs are increasing faster than the revenue and patients unpaid debts are on the rise.

When integrating a new telehealth program into your business, there are some details that employers should not overlook.